Publicacions científiques | Siidon | Guttmann

Cercador

Reader Response: Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort.

Autor/s:

Chen T, Chen S, Lin X.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 10

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210190

Reader Response: MRI-Based Prediction of Macrovascular Causes of Intracerebral Hemorrhage: The MACRO Score.

Autor/s:

Feng Q.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 11

https://www.neurology.org/doi/full/10.1212/WNL.0000000000213446

Reader Response: National and Subnational Trends of Mortality and Years of Life Lost Due to Stroke and Its Subtypes in Young Adults in China, 2005-2020.

Autor/s:

Liu Y.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 1

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210263

Reader Response: Seizures and Epilepsy in Association With Neurocysticercosis: a Nosologic Proposal.

Autor/s:

Carpio A, Yacubian EMT, Hamamoto Filho PT, Hauser WA, Kelvin EA.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 4

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210265

Reader Response: Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials.

Autor/s:

Huang J.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 3

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210312

Reader Response: Tenecteplase vs Alteplase in Acute Ischemic Stroke Within 4.5 Hours: A Systematic Review and Meta-Analysis of Randomized Trials.

Autor/s:

Ioli P.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 3

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210285

Reader Response: The Great Debate in Diagnosing Alzheimer Disease: More Than Just a β Test.

Autor/s:

Bieger A, Brum WS, Borelli WV, Ferrari-Souza JP, DaCosta JC, Castilhos RM, Schumacher Schuh AF, Pascoal T, Rosa-Neto P, Schilling LP, Zimmer ER.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 6

https://www.neurology.org/doi/full/10.1212/WNL.0000000000210159

Reader Response: The Time Has Come. The Time Is Now. IV Alteplase, Will You Please Go Now?

Autor/s:

Horowitz SH.

Letters to the Editor: Editors' Choice

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 5

https://www.neurology.org/doi/full/10.1212/WNL.0000000000213342

Article

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.

Autor/s:

Bilodeau PA, Wruble Clark M, Ganguly A, Harowitz JB, Mahler JV, Jiang M, Narasimhan SS, Pua DK, Healy BC, Mateen FJ, Levy M, Bhattacharyya S.

Any publicació:

2026

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

https://www.neurology.org/doi/full/10.1212/NXI.0000000000200536

Real-World Validation of the HERMES-24 Score for Outcome Prediction After Large Vessel Occlusion Treatment in Late Time Window Patients.

Autor/s:

Shirvani O, Bode FJ, Stösser S, Asperger H, Ebrahimi T, Klehr L, Layer J, Meissner J, Odensass S, Skobel A, Thielscher C, von Danwitz NM, Dorn F, Petzold GC, Weller JM; GSR-ET investigators.

Clinical/Scientific Notes

Any publicació:

2026

Número de revista:

Neurology vol. 106 n. 11

https://www.neurology.org/doi/full/10.1212/WNL.0000000000214908